Literature DB >> 34167119

Defining AKD: The Spectrum of AKI, AKD, and CKD.

Andrew S Levey1.   

Abstract

Kidney Disease Improving Global Outcomes (KDIGO) guidelines address the definition, classification, and management of acute kidney injury (AKI) and chronic kidney disease (CKD). In practice, some clinical presentations of acute kidney diseases and disorders (AKD) do not meet the criteria for AKI or CKD. In principle, these presentations may be caused by the same diseases that cause AKI or CKD, which could be detected, evaluated, and treated before they evolve to AKI or CKD. In 2020, KDIGO convened a consensus conference to review recent evidence on the epidemiology of AKD and harmonize the definition and classification of AKD to be consistent with KDIGO definitions and classifications of AKI and CKD.
© 2021 S. Karger AG, Basel.

Entities:  

Keywords:  Acute kidney disease; Acute kidney injury; Chronic kidney disease; Kidney Disease Improving Global Outcomes guidelines

Mesh:

Year:  2021        PMID: 34167119     DOI: 10.1159/000516647

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  7 in total

1.  Deoxycholate amphotericin for management of mucormycosis: a retrospective cohort study from South India.

Authors:  Nitin Gupta; Sourabh Srinivas; Anagha Harikumar; K Devaraja; Vishnu Teja Nallapati; Kavitha Saravu
Journal:  Infez Med       Date:  2022-09-01

Review 2.  Overview of Diagnostic Criteria and Epidemiology of Acute Kidney Injury and Acute Kidney Disease in the Critically Ill Patient.

Authors:  Bethany C Birkelo; Neesh Pannu; Edward D Siew
Journal:  Clin J Am Soc Nephrol       Date:  2022-03-15       Impact factor: 10.614

3.  Renal replacement therapy-requiring acute kidney injury due to tubulointerstitial nephritis and uveitis syndrome: case report.

Authors:  B Marahrens; K Amann; K Asmus; S Erfurt; D Patschan
Journal:  J Med Case Rep       Date:  2021-12-20

4.  Kidney Dysfunction and Its Progression in Patients Hospitalized Duo to COVID-19: Contribution to the Clinical Course and Outcomes.

Authors:  Katarzyna Kilis-Pstrusinska; Katarzyna Akutko; Joanna Braksator; Anna Dancewicz; Patrycja Grosman-Dziewiszek; Tatiana Jamer; Katarzyna Juszczyńska; Klaudia Konikowska; Marta Koruba; Małgorzata Pupek; Agnieszka Rusiecka; Krzysztof Kujawa; Barbara Adamik; Adrian Doroszko; Krzysztof Kaliszewski; Agnieszka Matera-Witkiewicz; Michał Pomorski; Marcin Protasiewicz; Janusz Sokołowski; Katarzyna Madziarska; Ewa A Jankowska
Journal:  J Clin Med       Date:  2021-11-25       Impact factor: 4.241

Review 5.  Acute Kidney Injury in COVID-19 Patients: Pathogenesis, Clinical Characteristics, Therapy, and Mortality.

Authors:  Venice Chávez-Valencia; Citlalli Orizaga-de-la-Cruz; Francisco Alejandro Lagunas-Rangel
Journal:  Diseases       Date:  2022-08-19

Review 6.  Burn-Induced Acute Kidney Injury-Two-Lane Road: From Molecular to Clinical Aspects.

Authors:  Andrei Niculae; Ileana Peride; Mirela Tiglis; Evgeni Sharkov; Tiberiu Paul Neagu; Ioan Lascar; Ionel Alexandru Checherita
Journal:  Int J Mol Sci       Date:  2022-08-05       Impact factor: 6.208

Review 7.  Acute Kidney Injury (AKI) in Young Synthetic Cannabinoids Abusers.

Authors:  Stefano D'Errico; Martina Zanon; Davide Radaelli; Monica Concato; Martina Padovano; Matteo Scopetti; Paola Frati; Vittorio Fineschi
Journal:  Biomedicines       Date:  2022-08-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.